Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemente García-Rizo

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 23, 2021
Prolactin, metabolic and immune parameters in naïve subjects with a first episode of psychosisClemente García-Rizo, Javier Vázquez-Bourgon, Javier Labad, et al.
International Journal of Molecular Sciences|February 11, 2023
Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell CulturesPatricia Gassó, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Acta Psychiatrica Scandinavica|May 19, 2026
Impact of Obstetric Complications in Subjects at Clinical High Risk for Psychosis: A Systematic Review and Meta-AnalysisInmaculada Baeza, Jordina Tor, Elena de la Serna, et al.
International Journal of Molecular Sciences|January 21, 2023
The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of SchizophreniaNina Treder, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Spanish Journal of Psychiatry and Mental Health|July 2, 2025
[Psychiatrists' attitudes towards the treatment of people with a first episode of psychosis in Catalonia]Maria Sagué-Vilavella, Daniel Berge, Miquel Bioque, et al.
Archives of Psychiatric Nursing|October 9, 2023
Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapineAndrea Mallorquí, Cristina Oliveira, Jose Rios, et al.
Clinical Drug Investigation|October 16, 2019
Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and ProlactinMeritxell Tost, José Antonio Monreal, Antonio Armario, et al.
Psychopharmacology|June 15, 2019
Food craving and consumption evolution in patients starting treatment with clozapineMarina Garriga, Andrea Mallorquí, Lourdes Serrano, et al.
Revista De Psiquiatria Y Salud Mental|February 17, 2020
Difficulties in delivery and depressive symptomatology in schizophreniaGisela Mezquida, Emilio Fernández-Egea, Devi Treen, et al.
Psychoneuroendocrinology|April 23, 2018
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesisVirginia Soria, Alexandre González-Rodríguez, Elena Huerta-Ramos, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 23, 2021
Prolactin, metabolic and immune parameters in naïve subjects with a first episode of psychosisClemente García-Rizo, Javier Vázquez-Bourgon, Javier Labad, et al.
International Journal of Molecular Sciences|February 11, 2023
Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell CulturesPatricia Gassó, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Acta Psychiatrica Scandinavica|May 19, 2026
Impact of Obstetric Complications in Subjects at Clinical High Risk for Psychosis: A Systematic Review and Meta-AnalysisInmaculada Baeza, Jordina Tor, Elena de la Serna, et al.
International Journal of Molecular Sciences|January 21, 2023
The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of SchizophreniaNina Treder, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Spanish Journal of Psychiatry and Mental Health|July 2, 2025
[Psychiatrists' attitudes towards the treatment of people with a first episode of psychosis in Catalonia]Maria Sagué-Vilavella, Daniel Berge, Miquel Bioque, et al.
Archives of Psychiatric Nursing|October 9, 2023
Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapineAndrea Mallorquí, Cristina Oliveira, Jose Rios, et al.
Clinical Drug Investigation|October 16, 2019
Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and ProlactinMeritxell Tost, José Antonio Monreal, Antonio Armario, et al.
Psychopharmacology|June 15, 2019
Food craving and consumption evolution in patients starting treatment with clozapineMarina Garriga, Andrea Mallorquí, Lourdes Serrano, et al.
Revista De Psiquiatria Y Salud Mental|February 17, 2020
Difficulties in delivery and depressive symptomatology in schizophreniaGisela Mezquida, Emilio Fernández-Egea, Devi Treen, et al.
Psychoneuroendocrinology|April 23, 2018
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesisVirginia Soria, Alexandre González-Rodríguez, Elena Huerta-Ramos, et al.
Pageof 6